TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.70
+1.60 (2.16%)
Apr 2, 2025, 1:30 PM CST

TTY Biopharm Company Income Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
5,8945,5065,0624,5364,222
Upgrade
Revenue Growth (YoY)
7.05%8.77%11.60%7.43%-5.47%
Upgrade
Cost of Revenue
2,4792,2182,0401,7681,617
Upgrade
Gross Profit
3,4153,2873,0212,7682,605
Upgrade
Selling, General & Admin
1,7501,6011,4361,3251,388
Upgrade
Research & Development
271.39310.44353.44287.6261.6
Upgrade
Other Operating Expenses
-1.444.950.381.43-2.28
Upgrade
Operating Expenses
2,0211,9151,7941,6271,647
Upgrade
Operating Income
1,3941,3721,2281,141957.38
Upgrade
Interest Expense
-38.26-35.18-22.85-18.97-19.41
Upgrade
Interest & Investment Income
92.2986.6637.5512.6721.4
Upgrade
Earnings From Equity Investments
400.05131.34116.38135.18162.87
Upgrade
Currency Exchange Gain (Loss)
24.970.7723.811.12-15.25
Upgrade
Other Non Operating Income (Expenses)
20.5317.2929.5-178.39101.01
Upgrade
EBT Excluding Unusual Items
1,8931,5731,4121,0921,208
Upgrade
Gain (Loss) on Sale of Investments
--35.74---1.56
Upgrade
Gain (Loss) on Sale of Assets
-0.95-1.93-3.28-0.74-0.32
Upgrade
Asset Writedown
-6.8-116.18-0.73-4.15-4.58
Upgrade
Pretax Income
1,8861,4191,4081,0871,202
Upgrade
Income Tax Expense
366.33300.86305.25264.81222.85
Upgrade
Earnings From Continuing Operations
1,5191,1191,103822.57978.68
Upgrade
Minority Interest in Earnings
-69.739.91-8.79.33-54.5
Upgrade
Net Income
1,4501,1291,094831.89924.18
Upgrade
Net Income to Common
1,4501,1291,094831.89924.18
Upgrade
Net Income Growth
28.46%3.12%31.55%-9.99%2.68%
Upgrade
Shares Outstanding (Basic)
249249249249249
Upgrade
Shares Outstanding (Diluted)
249249249249249
Upgrade
Shares Change (YoY)
0.04%0.03%-0.02%-0.00%0.03%
Upgrade
EPS (Basic)
5.834.544.403.353.72
Upgrade
EPS (Diluted)
5.824.534.403.343.71
Upgrade
EPS Growth
28.48%2.96%31.74%-9.97%2.77%
Upgrade
Free Cash Flow
1,2241,0071,1441,196358.25
Upgrade
Free Cash Flow Per Share
4.914.044.594.801.44
Upgrade
Dividend Per Share
4.2003.5003.4003.0004.000
Upgrade
Dividend Growth
20.00%2.94%13.33%-25.00%-
Upgrade
Gross Margin
57.94%59.70%59.69%61.03%61.70%
Upgrade
Operating Margin
23.65%24.93%24.26%25.15%22.68%
Upgrade
Profit Margin
24.60%20.50%21.62%18.34%21.89%
Upgrade
Free Cash Flow Margin
20.77%18.29%22.61%26.37%8.49%
Upgrade
EBITDA
1,5881,5661,4091,3031,111
Upgrade
EBITDA Margin
26.95%28.43%27.83%28.74%26.32%
Upgrade
D&A For EBITDA
194.26193.1180.69162.79153.86
Upgrade
EBIT
1,3941,3721,2281,141957.38
Upgrade
EBIT Margin
23.65%24.93%24.26%25.15%22.68%
Upgrade
Effective Tax Rate
19.43%21.20%21.67%24.35%18.55%
Upgrade
Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.